Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cumberland Pharmaceuticals (CPIX) Accumulated Depreciation & Amortization (2016 - 2025)

Cumberland Pharmaceuticals' Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $4.1 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 15.45% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 15.45% decrease, with the full-year FY2025 number at $4.1 million, down 15.45% from a year prior.
  • Accumulated Depreciation & Amortization hit $4.1 million in Q4 2025 for Cumberland Pharmaceuticals, down from $4.9 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for CPIX hit a ceiling of $5.3 million in Q4 2022 and a floor of $4.1 million in Q4 2025.
  • Historically, Accumulated Depreciation & Amortization has averaged $4.8 million across 5 years, with a median of $4.9 million in 2024.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 15.67% in 2022 and later fell 15.45% in 2025.
  • Tracing CPIX's Accumulated Depreciation & Amortization over 5 years: stood at $4.6 million in 2021, then grew by 15.67% to $5.3 million in 2022, then dropped by 7.36% to $4.9 million in 2023, then fell by 0.68% to $4.9 million in 2024, then fell by 15.45% to $4.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for CPIX at $4.1 million in Q4 2025, $4.9 million in Q4 2024, and $4.9 million in Q4 2023.